News

Cilostazol Matches Double-Dose Clopidogrel Following PCI


 

FROM THE ANNUAL MEETING OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dr. Kim said he had no relevant financial disclosures. Dr. Ohman said that he has been a consultant to a wide variety of pharmaceutical companies, including Sanofi-Aventis, Merck, Bristol-Myers Squibb, AstraZeneca, and Boehringer Ingelheim. He has received research support from Eli Lilly, Maquet, and Daiichi Sankyo. Dr. Stone said that he has also been a consultant to a variety of pharmaceutical companies. Dr. Dangas said that he has been a consultant to AstraZeneca and has received research grants from Sanofi-Aventis, Bristol-Myers Squibb, Eli Lilly, and Daiichi Sankyo.

Pages

Recommended Reading

Stem Cell Therapy Prompts 'Unprecedented' Myocardial Regeneration After MI
MDedge Internal Medicine
Transcatheter Valve Replacement Takes Center Stage
MDedge Internal Medicine
Post-MI Stem Cell Therapy Improves Cardiac Function
MDedge Internal Medicine
Stents Don't Surpass Pills in Stable CAD
MDedge Internal Medicine
Role of Patent Foramen Ovale Varies in Cryptogenic Strokes
MDedge Internal Medicine
Asymptomatic Carotid Disease Impairs Cognitive Function
MDedge Internal Medicine
Embolectomy May Help Despite Infarct Size
MDedge Internal Medicine
Infections, Pulmonary Complications Up Risk of Thrombotic Events
MDedge Internal Medicine
CoreValve Excels in 'Real-World' Study
MDedge Internal Medicine
Elective Angioplasty Safe at Hospitals Without Surgical Backup
MDedge Internal Medicine